Linked Life Data

11806283

Source:http://linkedlifedata.com/resource/pubmed/id/11806283

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
2002-1-24
pubmed:abstractText
The multiplicity of experimental models of angiogenesis in vitro and in vivo complicates the choice of a straightforward strategy to accurately identify the anti-angiogenic potential of a natural or synthetic compound with antitumoral activity. In the absence of such consensus, it is clear that the demonstration of an activity lies in the use of several models, both in vitro and in vivo. A rapid overview of the most currently used models, especially in vitro, is presented, with an emphasis on their limitations. Several examples of research strategies for identifying antitumoral anti-angiogenic compounds are used in illustration.
pubmed:language
fre
pubmed:journal
pubmed:citationSubset
IM
pubmed:status
MEDLINE
pubmed:issn
0040-5957
pubmed:author
pubmed:issnType
Print
pubmed:volume
56
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
473-81
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed:articleTitle
[Experimental models of angiogenesis (in vitro and in vivo)].
pubmed:affiliation
Institut de Recherches Servier, Division de Cancérologie Expérimentale, 11 rue des Moulineaux, 92150 Suresnes, France.
pubmed:publicationType
Journal Article, English Abstract, Review